Iron biofortification interventions to improve iron status and functional outcomes

Proceedings of the Nutrition Society
Q1
Jan 2019
Citations:40
Influential Citations:2
Systematic Reviews / Meta-Analyses
87
S2 IconPDF Icon

Enhanced Details

Methods
Three randomized, double-blind efficacy trials across the Philippines, India and Rwanda: Philippines involved 192 religious sisters in convents around Manila; India involved 246 adolescents aged 12–16 years in Maharashtra; Rwanda involved 195 iron-depleted adult women (18–27 years) attending university in Huye. All participants were randomized to iron-biofortified staple crops versus conventional staples.
Intervention
Rice (Philippines): iron-biofortified rice delivering 3.21 mg/kg Fe vs conventional rice 0.57 mg/kg Fe; daily ad libitum; duration 9 months. Pearl millet (India): iron-biofortified pearl millet delivering 86 mg/kg Fe vs conventional 21–52 mg/kg Fe; daily intake of 200–300 g as Bhakri flatbread; duration 6 months. Beans (Rwanda): iron-biofortified beans delivering 86 mg/kg Fe vs conventional 50 mg/kg Fe; consumed twice daily for 128 days (4.5 months).
Results
Iron-biofortified staples improved iron status in several trials (serum ferritin and total body iron increased; Hb increased in the Rwanda beans trial). In Philippines rice, non-anaemic participants showed ~20% increases in ferritin and total body iron. In India pearl millet, ferritin and total body iron rose after 4 months, with larger effects in baseline iron-deficient individuals. In Rwanda beans, Hb rose by 3.0 g/L; ferritin rose by 5.5 µg/L; total body iron rose by 1.5 mg/kg. Cognitive outcomes were evaluated in subsets and showed improvements in attention and memory with iron-biofortified crops, particularly for pearl millet (improvements across attention measures and cued recognition memory). No significant endline effects on anaemia were observed across trials. These findings suggest potential health benefits for cognitive function and iron status in at-risk populations, but additional well-designed trials are needed to confirm effects on health outcomes and explore broader populations and longer-term impacts.
Limitations
Limitations include a small number of trials (n=3) with different crops and populations; durations ranged from 4.5 to 9 months; heterogeneity in study design and outcomes; some risk of bias and incomplete reporting in sub-studies; cognitive outcomes often analyzed in subgroups; insufficient data on long-term health outcomes or physical performance.

Abstract

This analysis was conducted to evaluate the evidence of the efficacy of iron biofortification interventions on iron status and functional outcomes. Iron deficiency is a major public health problem worldwide, with a disproportionate impact on women an...